These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 1352714

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE.
    J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
    [Abstract] [Full Text] [Related]

  • 23. The psychological consequences of tardive dyskinesia. The effect of drug-induced parkinsonism and the topography of the dyskinetic movements.
    Brown KW, White T.
    Br J Psychiatry; 1991 Sep; 159():399-403. PubMed ID: 1683594
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Neuroleptic-induced respiratory dyskinesia.
    Kruk J, Sachdev P, Singh S.
    J Neuropsychiatry Clin Neurosci; 1995 Sep; 7(2):223-9. PubMed ID: 7626967
    [Abstract] [Full Text] [Related]

  • 26. Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy.
    Bitton V, Melamed E.
    J Clin Psychiatry; 1984 Jan; 45(1):28-30. PubMed ID: 6141157
    [Abstract] [Full Text] [Related]

  • 27. The influence of topography on the cognitive and psychopathological effects of tardive dyskinesia.
    Brown KW, White T.
    Am J Psychiatry; 1992 Oct; 149(10):1385-9. PubMed ID: 1356314
    [Abstract] [Full Text] [Related]

  • 28. Tardive dyskinesia in the aged. Duration of treatment relationships.
    Toenniessen LM, Casey DE, McFarland BH.
    Arch Gen Psychiatry; 1985 Mar; 42(3):278-84. PubMed ID: 2858189
    [Abstract] [Full Text] [Related]

  • 29. Vitamin E in the treatment of tardive dyskinesia.
    Akhtar S, Jajor TR, Kumar S.
    J Postgrad Med; 1993 Mar; 39(3):124-6. PubMed ID: 7914238
    [Abstract] [Full Text] [Related]

  • 30. Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication.
    Glazer WM, Morgenstern H, Schooler N, Berkman CS, Moore DC.
    Br J Psychiatry; 1990 Oct; 157():585-92. PubMed ID: 1983390
    [Abstract] [Full Text] [Related]

  • 31. Fine force instability: a quantitative measure of neuroleptic-induced dyskinesia in the hand.
    Caligiuri MP, Lohr JB.
    J Neuropsychiatry Clin Neurosci; 1990 Oct; 2(4):395-8. PubMed ID: 1983784
    [Abstract] [Full Text] [Related]

  • 32. Neuroleptic-induced parkinsonism in older schizophrenics.
    Hoffman WF, Labs SM, Casey DE.
    Biol Psychiatry; 1987 Apr; 22(4):427-39. PubMed ID: 2882787
    [Abstract] [Full Text] [Related]

  • 33. Vulnerability to tardive dyskinesia.
    Wolf ME, DeWolfe AS, Ryan JJ, Lips O, Mosnaim AD.
    J Clin Psychiatry; 1985 Sep; 46(9):367-8. PubMed ID: 2863257
    [Abstract] [Full Text] [Related]

  • 34. Neurochemical findings in the cerebrospinal fluid of schizophrenic patients with tardive dyskinesia and neuroleptic-induced parkinsonism.
    Saito T, Ishizawa H, Tsuchiya F, Ozawa H, Takahata N.
    Jpn J Psychiatry Neurol; 1986 Jun; 40(2):189-94. PubMed ID: 2431183
    [Abstract] [Full Text] [Related]

  • 35. Risperidone-induced tardive dyskinesia and parkinsonism.
    Gwinn KA, Caviness JN.
    Mov Disord; 1997 Jan; 12(1):119-21. PubMed ID: 8990067
    [No Abstract] [Full Text] [Related]

  • 36. The coexistence of parkinsonism-like symptoms and tardive dyskinesia.
    Richardson MA, Craig TJ.
    Am J Psychiatry; 1982 Mar; 139(3):341-3. PubMed ID: 6120656
    [Abstract] [Full Text] [Related]

  • 37. Rate of tardive dyskinesia in hospitalized patients.
    Ross DE, Thomas M, Booth M, Weinborn M.
    Am J Psychiatry; 2005 Apr; 162(4):816. PubMed ID: 15800173
    [No Abstract] [Full Text] [Related]

  • 38. Neuroleptic-induced tardive dyskinesia and parkinsonism: changes during several years of continuing treatment.
    Casey DE, Povlsen UJ, Meidahl B, Gerlach J.
    Psychopharmacol Bull; 1986 Apr; 22(1):250-3. PubMed ID: 2873612
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. "Positive" and "negative" movement disorders in schizophrenia.
    Sandyk R, Kay SR.
    Int J Neurosci; 1992 Oct; 66(3-4):143-51. PubMed ID: 1305614
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.